Quick Answer
CYTOKINETICS INC reported R&D Expense of $416.03 million for fiscal year 2025.
CYTOKINETICS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $416.03M | +22.6% |
| 2024 | $339.41M | +2.8% |
| 2023 | $330.12M | +37.1% |
| 2022 | $240.81M | +50.6% |
| 2021 | $159.94M | +65.0% |
| 2020 | $96.95M | +12.6% |
| 2019 | $86.12M | -3.4% |
| 2018 | $89.14M | -1.3% |
| 2017 | $90.30M | +50.8% |
| 2016 | $59.90M | +29.1% |
| 2015 | $46.40M | +4.4% |
| 2014 | $44.43M | -10.2% |
| 2013 | $49.45M | +38.7% |
| 2012 | $35.64M | -4.1% |
| 2011 | $37.18M | -2.2% |
| 2010 | $38.01M | -4.6% |
| 2009 | $39.84M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $99.23M | +17.3% | -11.8% |
| June 30, 2025 | $112.55M | +41.4% | +12.7% |
| March 31, 2025 | $99.84M | +22.4% | +18.0% |
| September 30, 2024 | $84.61M | +2.5% | +6.3% |
| June 30, 2024 | $79.60M | -4.3% | -2.4% |
| March 31, 2024 | $81.57M | +2.7% | -1.2% |
| September 30, 2023 | $82.53M | +31.6% | -0.8% |
| June 30, 2023 | $83.19M | +45.6% | +4.8% |
- CYTOKINETICS INC showed an increase of +22.6% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, CYTOKINETICS INC’s r&d expense has grown by 944.2% (from $39.84 million to $416.03 million).
- The most recent figure is from CYTOKINETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: